TY - JOUR
T1 - Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer
T2 - A Retrospective Study at Two Institutions
AU - Yagi, Ryoma
AU - Shimada, Yoshifumi
AU - Kameyama, Hitoshi
AU - Tajima, Yosuke
AU - Okamura, Takuma
AU - Sakata, Jun
AU - Kobayashi, Takashi
AU - Kosugi, Shin ichi
AU - Wakai, Toshifumi
AU - Nogami, Hitoshi
AU - Maruyama, Satoshi
AU - Takii, Yasumasa
AU - Kawasaki, Takashi
AU - Honma, Kei ichi
N1 - Publisher Copyright:
© 2016, The Author(s).
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background: The presence of extramural tumor deposits without lymph node structure (EX) is an important prognostic factor for patients with colorectal cancer. However, the clinical significance of EX in the lateral pelvic lymph node area (LP-EX) remains unclear. This study aimed to determine the prognostic implications of LP-EX for patients with low rectal cancer. Methods: This retrospective study involved 172 consecutive patients with stage 2 or 3 low rectal cancer who underwent curative surgery including lateral pelvic lymph node (LPLN) dissection. The patients were classified into the following three groups according to the metastatic status of the LPLN area: patients without metastasis (no-LP-M group), patients with lymph node metastasis (LP-LNM group), and patients with EX (LP-EX group). Potential prognostic factors of overall survival (OS) and relapse-free survival (RFS) were identified in uni- and multivariate analyses. Results: Classification assigned 131 patients (76 %) to the no-LP-M group, 27 patients (16 %) to the LP-LNM group, and 14 patients (8 %) to the LP-EX group. The 5-year OS rate was 80.3 % in the no-LP-M group, 61.1 % in the LP-LNM group, and 34.9 % in the LP-EX group (P < 0.001). The corresponding 5-year RFS rates were 62.2, 33.8, and 14.3 %, respectively (P < 0.001). A multivariate Cox proportional hazards regression analysis showed that the presence of LP-EX was an independent prognostic factor for OS (P = 0.006) and RFS (P = 0.001). Conclusions: The LP-EX classification is a useful pathologic parameter that can be used to stratify patients with metastasis in the LPLN area.
AB - Background: The presence of extramural tumor deposits without lymph node structure (EX) is an important prognostic factor for patients with colorectal cancer. However, the clinical significance of EX in the lateral pelvic lymph node area (LP-EX) remains unclear. This study aimed to determine the prognostic implications of LP-EX for patients with low rectal cancer. Methods: This retrospective study involved 172 consecutive patients with stage 2 or 3 low rectal cancer who underwent curative surgery including lateral pelvic lymph node (LPLN) dissection. The patients were classified into the following three groups according to the metastatic status of the LPLN area: patients without metastasis (no-LP-M group), patients with lymph node metastasis (LP-LNM group), and patients with EX (LP-EX group). Potential prognostic factors of overall survival (OS) and relapse-free survival (RFS) were identified in uni- and multivariate analyses. Results: Classification assigned 131 patients (76 %) to the no-LP-M group, 27 patients (16 %) to the LP-LNM group, and 14 patients (8 %) to the LP-EX group. The 5-year OS rate was 80.3 % in the no-LP-M group, 61.1 % in the LP-LNM group, and 34.9 % in the LP-EX group (P < 0.001). The corresponding 5-year RFS rates were 62.2, 33.8, and 14.3 %, respectively (P < 0.001). A multivariate Cox proportional hazards regression analysis showed that the presence of LP-EX was an independent prognostic factor for OS (P = 0.006) and RFS (P = 0.001). Conclusions: The LP-EX classification is a useful pathologic parameter that can be used to stratify patients with metastasis in the LPLN area.
UR - http://www.scopus.com/inward/record.url?scp=84978152217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978152217&partnerID=8YFLogxK
U2 - 10.1245/s10434-016-5379-9
DO - 10.1245/s10434-016-5379-9
M3 - Article
AN - SCOPUS:84978152217
SN - 1068-9265
VL - 23
SP - 552
EP - 558
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
ER -